文献速递心脑血管急症消化、代谢与肾脏急症

经导管主动脉瓣植入术后胃肠道血管发育不良的消退

Gastrointestinal Angiodysplasia Resolution After Transcatheter Aortic Valve Implantation.
PubMed 文献 · JAMA Netw Open · 2024-10-01
一句话结论在合并缺铁性贫血的重度主动脉瓣狭窄患者中,经导管主动脉瓣植入与胃肠道血管发育不良数量减少相关,血管发育不良消退可能减少消化道出血,对Heyde综合征有双重获益。

该前瞻性单中心队列研究纳入2020年9月至2022年2月等待经导管主动脉瓣植入(TAVI)的缺铁性贫血患者,用胶囊内镜评估胃肠道血管病变,有病变者在TAVI后6个月复查。24例中18例(75.0%)存在血管病变,15例接受TAVI,11例完成第二次胶囊内镜。血管病变平均数量从TAVI前6.4个降至TAVI后6个月2.0个(P = .04),9/11例(81.8%)病变减少,6例(54.5%)典型血管发育不良消失。合并多瓣膜心脏病者血管发育不良消退比例低于无多瓣膜病者(0/3 vs 6/8,75.0%),TAVI后显著瓣周漏者低于无显著瓣周漏者(2/5,40.0% vs 4/6,66.7%)。作者认为TAVI可能通过消退血管病变减少消化道出血。

要点

  • 等待TAVI的缺铁性贫血合并重度主动脉瓣狭窄患者中,胶囊内镜检出胃肠道血管病变者占75.0%(18/24)。
  • 11例完成TAVI前后两次胶囊内镜者,胃肠道血管病变平均数量从6.4个降至2.0个(P = .04)。
  • 9/11例(81.8%)TAVI后血管病变数量减少,其中6例(54.5%)典型血管发育不良消失。
  • 合并多瓣膜心脏病者血管发育不良消退为0/3例,无多瓣膜病者为6/8例(75.0%);TAVI后显著瓣周漏者为2/5例(40.0%),无显著瓣周漏者为4/6例(66.7%)。

适用人群与场景

  • 等待TAVI、合并缺铁性贫血的重度主动脉瓣狭窄患者,来自2020年9月至2022年2月的TAVI等待名单。

研究设计与关键结果

  • 前瞻性单中心队列研究:24例等待TAVI的缺铁性贫血合并重度主动脉瓣狭窄患者接受胶囊内镜,平均(SD)年龄77.4(7.1)岁,男性18例(75.0%)。
  • 胶囊内镜检出胃肠道血管病变18例(75.0%);18例中15例接受TAVI,其中11例同意第二次胶囊内镜。
  • 主要终点:全胃肠道血管病变平均(SD)数量从TAVI前6.4(5.6)个降至TAVI后6个月2.0(2.1)个(P = .04)。
  • 11例中9例(81.8%)血管病变数量减少,6例(54.5%)不再有典型血管发育不良。
  • TAVI前合并多瓣膜心脏病者血管发育不良消退0/3例,无多瓣膜心脏病者6/8例(75.0%)。
  • TAVI后存在显著瓣周漏者血管发育不良消退2/5例(40.0%),无显著瓣周漏者4/6例(66.7%)。

证据类型、等级与局限

  • 证据类型:前瞻性单中心队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现提示TAVI不仅改善主动脉瓣狭窄,还可能通过消退血管病变减少胃肠道出血,对Heyde综合征患者有双重获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Heyde syndrome is the cooccurrence of aortic stenosis and gastrointestinal bleeding secondary to vascular lesions, including angiodysplasias. Several studies have demonstrated cessation of gastrointestinal bleeding after transcatheter aortic valve implantation (TAVI), but the etiology and effects on vascular lesions are largely unknown.

OBJECTIVE: To examine the associations of TAVI with gastrointestinal vascular lesions and identify factors associated with recovery among patients with iron deficiency anemia and severe aortic stenosis.

DESIGN, SETTING, AND PARTICIPANTS: In this prospective, single-center cohort study, patients with iron deficiency anemia on the TAVI waiting list from September 2020 to February 2022 were assessed by capsule endoscopy. Those with vascular lesions were reassessed 6 months after TAVI. Endoscopic images were anonymized and evaluated by 2 independent researchers. Data were analyzed from September 2022 to August 2024.

MAIN OUTCOMES AND MEASURES: The primary outcome was the mean difference in the number of vascular lesions before vs after TAVI.

RESULTS: A total of 24 patients (mean [SD] age, 77.4 [7.1] years; 18 [75.0%] male) underwent capsule endoscopy, and vascular lesions were present in 18 patients (75.0%). TAVI was performed in 15 of 18 patients with vascular lesions, of whom 11 agreed to a second capsule endoscopy. The mean (SD) number of vascular lesions across the gastrointestinal tract decreased from 6.4 (5.6) lesions before TAVI to 2.0 (2.1) lesions 6 months after TAVI (P = .04). The number of vascular lesions decreased in 9 of 11 patients (81.8%), including 6 patients (54.5%) who no longer had typical angiodysplasias. Resolution of angiodysplasias was less frequent in patients who had multiple valvular heart disease before TAVI (0 of 3 patients) vs those without multiple valvular heart disease (6 of 8 patients [75.0%]) and in patients with significant paravalvular leakage after TAVI (2 of 5 patients [40.0%]) vs those without significant leakage (4 of 6 patients [66.7%]).

CONCLUSIONS AND RELEVANCE: In this cohort study of 24 patients with iron deficiency anemia and severe aortic stenosis, angiodysplasias were present in 75.0% of patients. TAVI was associated with reduced size and number of angiodysplasias in these patients. These findings suggest that TAVI not only improves aortic stenosis but may also reduce gastrointestinal bleeding by resolving vascular lesions, offering a dual benefit for patients with Heyde syndrome.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Goltstein LCMJ, Rooijakkers MJP, Thierens NDE, et al. Gastrointestinal Angiodysplasia Resolution After Transcatheter Aortic Valve Implantation. JAMA Netw Open. 2024. PMID: 39476231. doi:10.1001/jamanetworkopen.2024.42324

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。